BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

232 related articles for article (PubMed ID: 1975893)

  • 1. Prevention of relapses in Wegener's granulomatosis by treatment based on antineutrophil cytoplasmic antibody titre.
    Tervaert JW; Huitema MG; Hené RJ; Sluiter WJ; The TH; van der Hem GK; Kallenberg CG
    Lancet; 1990 Sep; 336(8717):709-11. PubMed ID: 1975893
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Are antineutrophil cytoplasmic antibodies a marker predictive of relapse in Wegener's granulomatosis? A prospective study.
    Girard T; Mahr A; Noël LH; Cordier JF; Lesavre P; André MH; Guillevin L
    Rheumatology (Oxford); 2001 Feb; 40(2):147-51. PubMed ID: 11257150
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antineutrophil cytoplasmic antibody (C-ANCA) levels in relation to the treatment of Wegener's granulomatosis].
    Maguchi S; Takizawa M; Miyatake Y; Nakamuru Y; Fukuda S; Inuyama Y
    Nihon Jibiinkoka Gakkai Kaiho; 1995 Jun; 98(6):974-83. PubMed ID: 7629651
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum markers of T cell activation in relapses of Wegener's granulomatosis.
    Stegeman CA; Tervaert JW; Huitema MG; Kallenberg CG
    Clin Exp Immunol; 1993 Mar; 91(3):415-20. PubMed ID: 8443965
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Severe CNS manifestations as the clinical hallmark in generalized Wegener's granulomatosis consistently negative for antineutrophil cytoplasmic antibodies (ANCA). A report of 3 cases and a review of the literature.
    Reinhold-Keller E; de Groot K; Holl-Ulrich K; Arlt AC; Heller M; Feller AC; Gross WL
    Clin Exp Rheumatol; 2001; 19(5):541-9. PubMed ID: 11579713
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive Granulomatosis With Polyangiitis (Wegener's) Is a Clinically Distinct Subset of ANCA-Associated Vasculitis: A Retrospective Analysis of 315 Patients From a German Vasculitis Referral Center.
    Schirmer JH; Wright MN; Herrmann K; Laudien M; Nölle B; Reinhold-Keller E; Bremer JP; Moosig F; Holle JU
    Arthritis Rheumatol; 2016 Dec; 68(12):2953-2963. PubMed ID: 27333332
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cyclophosphamide pulse therapy in Wegener's granulomatosis.
    Haubitz M; Frei U; Rother U; Brunkhorst R; Koch KM
    Nephrol Dial Transplant; 1991; 6(8):531-5. PubMed ID: 1956550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Subarachnoid haemorrhage in Wegener's granulomatosis, with negative four vessel angiography.
    Venning MC; Burn DJ; Bashir SH; Deopujari CE; Mendelow AD
    Br J Neurosurg; 1991; 5(2):195-8. PubMed ID: 1863381
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of nonsevere relapses in antineutrophil cytoplasmic antibody-associated vasculitis treated with glucocorticoids.
    Miloslavsky EM; Specks U; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Ding L; Iklé D; Villareal M; Lim N; Brunetta P; Fervenza FC; Monach PA; Stone JH;
    Arthritis Rheumatol; 2015 Jun; 67(6):1629-36. PubMed ID: 25776953
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Neutrophil cytoplasmic autoantibodies and Wegener's granulomatosis.
    Lancet; 1989 Feb; 1(8632):269-70. PubMed ID: 2563425
    [No Abstract]   [Full Text] [Related]  

  • 11. Myeloperoxidase-Antineutrophil Cytoplasmic Antibody (ANCA)-Positive and ANCA-Negative Patients With Granulomatosis With Polyangiitis (Wegener's): Distinct Patient Subsets.
    Miloslavsky EM; Lu N; Unizony S; Choi HK; Merkel PA; Seo P; Spiera R; Langford CA; Hoffman GS; Kallenberg CG; St Clair EW; Tchao NK; Fervenza F; Monach PA; Specks U; Stone JH
    Arthritis Rheumatol; 2016 Dec; 68(12):2945-2952. PubMed ID: 27428559
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Negative ANCA in Wegener's granulomatosis.
    Carrie S; Hughes KB; Watson MG
    J Laryngol Otol; 1994 May; 108(5):420-2. PubMed ID: 8035124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes in proteinase 3 anti-neutrophil cytoplasm autoantibody levels in early systemic granulomatosis with polyangiitis (Wegener's) may reflect treatment rather than disease activity.
    Rasmussen N; Salmela A; Ekstrand A; de Groot K; Gregorini G; Cohen Tervaert JW; Gross WL; Wiik A; Jayne DR;
    Clin Exp Rheumatol; 2013; 31(1 Suppl 75):S38-44. PubMed ID: 23380137
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of disease manifestation and antineutrophil cytoplasmic antibody titer on the response to pulse cyclophosphamide therapy in patients with Wegener's granulomatosis.
    Reinhold-Keller E; Kekow J; Schnabel A; Schmitt WH; Heller M; Beigel A; Duncker G; Gross WL
    Arthritis Rheum; 1994 Jun; 37(6):919-24. PubMed ID: 8003065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titer in patients with Wegener's granulomatosis.
    Kerr GS; Fleisher TA; Hallahan CW; Leavitt RY; Fauci AS; Hoffman GS
    Arthritis Rheum; 1993 Mar; 36(3):365-71. PubMed ID: 8452581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wegener's granulomatosis--treatment under revision?
    Puolijoki H; Liippo K; Raitio M; Tala E
    Respiration; 1992; 59(2):116-8. PubMed ID: 1620980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to neutrophil cytoplasmic antigens (ANCA) do not bind to polymorphonuclear neutrophils in blood.
    Abdel-Salam B; Iking-Konert C; Schneider M; Andrassy K; Hänsch GM
    Kidney Int; 2004 Sep; 66(3):1009-17. PubMed ID: 15327394
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Limited prognostic value of changes in antineutrophil cytoplasmic antibody titers in patients with Wegener's granulomatosis.
    Kerr GS; Fleisher TA; Hallahan CW; Leavitt RY; Fauci AS; Hoffman GS
    Adv Exp Med Biol; 1993; 336():411-4. PubMed ID: 8296645
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relevance of classic anti-neutrophil cytoplasmic autoantibody (C-ANCA)-mediated inhibition of proteinase 3-alpha 1-antitrypsin complexation to disease activity in Wegener's granulomatosis.
    Dolman KM; Stegeman CA; van de Wiel BA; Hack CE; von dem Borne AE; Kallenberg CG; Goldschmeding R
    Clin Exp Immunol; 1993 Sep; 93(3):405-10. PubMed ID: 8370167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of a cyclophosphamide-induction methotrexate-maintenance regimen for the treatment of Wegener's granulomatosis: extended follow-up and rate of relapse.
    Langford CA; Talar-Williams C; Barron KS; Sneller MC
    Am J Med; 2003 Apr; 114(6):463-9. PubMed ID: 12727579
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.